Lynwood Capital Management »

Cingulate shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Cingulate (CINGW) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Cingulate

Tip: Access up to 7 years of quarterly data

All positions including Cingulate held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cingulate by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.3k 50k 0.17
2023-06-30 $11k 50k 0.21
2023-03-31 $8.6k 50k 0.17
2022-12-31 $11k 50k 0.22
2022-09-30 $11k 50k 0.22
2022-06-30 $12k 50k 0.24
2022-03-31 $20k 50k 0.40
2021-12-31 $36k 50k 0.72

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Cingulate

Hudson Bay Capital Management
Virtu Financial
GoalVest Advisory
UBS Group

View all funds holding Cingulate